new_0222_0291|PLRX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0291|PLRX|1|Pliant Therapeutics Inc Total Current Assets (Quarterly) (USD)|Pliant Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Pliant Therapeutics Inc Inventories (Quarterly) (USD)|Pliant Therapeutics Inc Net PP&E (Quarterly) (USD)|Pliant Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Pliant Therapeutics Inc Total Liabilities (Quarterly) (USD)|Pliant Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Pliant Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Pliant Therapeutics Inc Total Deposits (Quarterly) (USD)|Pliant Therapeutics Inc Book Value (Quarterly) (USD)|Pliant Therapeutics Inc Retained Earnings (Quarterly) (USD)|Pliant Therapeutics Inc Treasury Stock (Quarterly) (USD)|Pliant Therapeutics Inc EV to Revenues|Pliant Therapeutics Inc EV to Earnings|Pliant Therapeutics Inc EV to Free Cash Flow|Pliant Therapeutics Inc EV to Assets (Quarterly)|Pliant Therapeutics Inc PS Ratio|Pliant Therapeutics Inc PE Ratio|Pliant Therapeutics Inc Price to Book Value|Pliant Therapeutics Inc PEG Ratio|Pliant Therapeutics Inc Debt to Equity Ratio|Pliant Therapeutics Inc Dividend Yield|Pliant Therapeutics Inc Shareholder Yield (TTM)|Pliant Therapeutics Inc Percent of Shares Outstanding Short|Pliant Therapeutics Inc Total Receivables (Quarterly) (USD)|Pliant Therapeutics Inc Total Payables (Quarterly) (USD)|Pliant Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Pliant Therapeutics Inc Return on Invested Capital|Pliant Therapeutics Inc Quality Ratio Score|Pliant Therapeutics Inc Momentum Score|Pliant Therapeutics Inc Beta (1Y)|Pliant Therapeutics Inc Sustainable Growth Rate (TTM)|Pliant Therapeutics Inc Institutional Investor Ownership Percentage|Pliant Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Pliant Therapeutics Inc Total Employees (Annual)|Pliant Therapeutics Inc EPS Diluted (Quarterly) (USD)|Pliant Therapeutics Inc Shares Outstanding|Pliant Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Pliant Therapeutics Inc Ordinary Shares Number (Quarterly)|Pliant Therapeutics Inc Payout Ratio|Pliant Therapeutics Inc Quick Ratio (Quarterly)|Pliant Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Pliant Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Pliant Therapeutics Inc Effective Tax Rate (TTM)|Pliant Therapeutics Inc Return on Equity|Pliant Therapeutics Inc Net Income (TTM) (USD)|Pliant Therapeutics Inc Revenue (TTM) (USD)|Pliant Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Pliant Therapeutics Inc Revenue (Quarterly) (USD)|Pliant Therapeutics Inc Gross Profit (Quarterly) (USD)|Pliant Therapeutics Inc SG&A Expense (Quarterly) (USD)|Pliant Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Pliant Therapeutics Inc Net Income (Quarterly) (USD)|Pliant Therapeutics Inc Net Interest Income (Quarterly) (USD)|Pliant Therapeutics Inc Price (USD)|Pliant Therapeutics Inc Total Return Price (USD)|Pliant Therapeutics Inc Enterprise Value (USD)|Pliant Therapeutics Inc 30-Day Average Daily Volume|Pliant Therapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0291|PLRX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0291|PLRX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|yearly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0291|PLRX|5|91.2857142857|91.2857142857||91.2857142857||91.2857142857|91.2857142857|91.2857142857||91.2857142857|91.2857142857||1.44699140401|91.25|1.44444444444|91.4|1.44571428571|1.44444444444|1.44341801386|1.4387755102|91.2857142857|1.44444444444|91.25|15.2564102564|91.2857142857|91.2857142857|91.2857142857|91.25||30.6666666667|30.7142857143|91.25||91.4|366|91.4|35.2||91.2857142857|91.25|91.2857142857|91.4|91.4444444444||91.25|91.2857142857|91.25||91.2857142857||91.4|91.4|91.4|91.4|1.44341801386|1.44341801386|1.44444444444|1.44416873449|1.43888888889||
new_0222_0291|PLRX|6|7|7||7||7|7|7||7|7||349|4|432|5|350|18|433|98|7|432|4|39|7|7|7|4||6|7|4||10|1|10|15||7|4|7|10|9||4|7|4||7||10|10|10|10|433|433|432|403|180||
new_0222_0291|PLRX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0291|PLRX|201903||||||||||||||||||||||||||||||||||22.8611||-0.7039||||||-0.7039|||||||||2.601|-14.023|-14.023|0.313|||||||
new_0222_0291|PLRX|201906||||||||||||||||||||||||||||||||||22.8611||-0.7733||||||-0.679|-0.132||||||||2.643|-15.522|-15.522|0.24|||||||
new_0222_0291|PLRX|201909||||||||||||||||||||||||||||||||||22.8611||-0.6702||||||-0.5798|-0.014||||||||2.583|-13.255|-13.255|0.148|||||||
new_0222_0291|PLRX|201912|111.9|102.773||4.079||119.499|8.172|111.327||-76.295|-76.295||||||||||||||7.385|1.25|75.861|||||||22.8611|62|1.4784|||31.243||13.4799|1.8446|0.146|||-0.631|||57.052||3.103|42.169|42.169|0.115|||||||
new_0222_0291|PLRX|202003|176.079|141.431||4.201||10.495|9.564|0.931||173.562|-65.266||||||||||||||32.023|2.532|0.003|||||||31.243|||31.243||35.4272||18.1361|0.353||||24.421|||28.938||4.011|11.029|11.029|0.021|||||||
new_0222_0291|PLRX|202006|324.323|312.468||4.029||12.987|12.036|0.951||315.816|-82.267||||52.2783|2.5471||1011.0684|3.6413|||||0.4488|3.682|2.483|0.003|||||||12.2539||-1.39|35.4272||35.4272||26.267|-1.39|-163.119|||22.942|||3.6||3.04|-17.001|-17.001|0.111|32.46|32.46|837.4989|99118.1333||23.29|25.15
new_0222_0291|PLRX|202009|307.729|294||4.144||11.978|11.026|0.952||300.346|-98.801||5.3949|25.9013|34.3447|1.6307|6.1063||2.6746||||-20.0187|3.2205|7.214|3.14|0.003|9.9649||||11.0245||35.4455||-0.47|35.4657||35.4657||27.3185|-0.47|2.163||11.0245|19.663|94.404||4.814||4.591|-16.534|-16.534|0.127|22.65|22.65|509.2981|160648.9333||21.62|27.52
new_0222_0291|PLRX|202012|290.754|276.894||4.321||12.465|11.599|0.866||283.061|-117.828||12.695|-12.7818|-13.681|1.7963|15.5519||2.8537||||-19.9008|2.613|9.362|2.023|0.003|-19.3654||||-20.8396||35.5528|78|-0.54|35.5528||35.5528||24.6794|-0.54|0.205||-20.8396|-41.533|41.817||4.465||5.627|-19.027|-19.027|0.355|22.72|22.72|530.8656|94003.2667||24.61|33.09
new_0222_0291|PLRX|202103|270.537|264.1||4.266||11.085|10.25|0.835||264.169|-140.684||75.8573|-15.1407|-28.8295|4.1485|77.6629||5.3223||||-11.4334|4.998|2.257|2.886|0.003|-28.2052||||-28.2052||35.6452||-0.64|35.7483||35.7483||25.986|-0.64|||-28.2052|-75.418|15.053||2.174||6.566|-22.856|-22.856|0.063|39.33|39.33|1141.8806|263864.6||33.5|30.06
new_0222_0291|PLRX|202106|250.719|243.981||4.367||11.736|10.932|0.804||243.98|-163.515||60.4202|-9.8474|-11.9174|3.1288|78.2814||4.2793||||0.2268|4.659|1.913|2.764|0.003|-28.8651||2|1.1742|-28.8651||35.7469||-0.64|35.8539||35.8539||22.493|-0.64|||-28.8651|-81.248|13.242||1.789||5.475|-22.831|-22.831|0.073|29.12|29.12|800.0846|107089.0667|-10.2896|20.2|18.24
new_0222_0291|PLRX|202109|228.584|221.044||4.706||13.681|12.925|0.756||220.44|-190.56||38.4791|-4.2094|-5.2189|1.6498|60.055||2.7549|-0.0115|||-0.3685|5.1655|1.693|2.605|0.003|-34.9692||2|1.5319|-34.9692||35.9063||-0.75|35.9773||35.9773||17.233|-0.75|-2.443||-34.9692|-91.759|10.038||1.61||7.671|-27.045|-27.045|0.068|16.88|16.88|386.2528|163651.6|-25.4746|15.93|14.18
new_0222_0291|PLRX|202112|||||||||||||26.4477||-3.5871||48.0298||2.2071|-0.0092||||5.6149||||||2|0.29||||||||||||||||||||||||13.5|13.5|265.4825|202082.1|-40.581|11.73|9.92